Jonathan H. Watanabe

1.4k total citations · 2 hit papers
63 papers, 973 citations indexed

About

Jonathan H. Watanabe is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Jonathan H. Watanabe has authored 63 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 17 papers in Geriatrics and Gerontology and 15 papers in Epidemiology. Recurrent topics in Jonathan H. Watanabe's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Medication Adherence and Compliance (10 papers). Jonathan H. Watanabe is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Medication Adherence and Compliance (10 papers). Jonathan H. Watanabe collaborates with scholars based in United States, Canada and Australia. Jonathan H. Watanabe's co-authors include Jan D. Hirsch, Mark Bounthavong, Bin Nan, John P. Ney, Johann Strauß, Vaishali Patel, Timothy F. Chen, Sean D. Sullivan, Rafael Alfonso‐Cristancho and David N. van der Goes and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Journal of the American Geriatrics Society.

In The Last Decade

Jonathan H. Watanabe

54 papers receiving 914 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cost of Prescription Drug–Related Morbidity and Mortality

2018 241 citations Jonathan H. Watanabe, Jan D. Hirsch et al. profile →
Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022

2023 86 citations Jonathan H. Watanabe, Bin Nan et al. Journal of the American Pharmacists Association profile →

Peers

Jonathan H. Watanabe

PHEOH

SURGE

Christopher Zacker United States

Junling Wang United States

Jeffrey J. Ellis United States

Euni Lee South Korea

Saira Jan United States

Kavita V. Nair United States

N. O’Flynn United Kingdom

Colette B. Raymond Canada

Shu Chuen Li Australia

Emily R. Cox Australia

Christopher Zacker United States

Jonathan H. Watanabe

134 ×0.6

244 ×1.1

149 ×0.8

PHEOH

230 ×1.4

163 ×1.4

SURGE

Citations per year, relative to Jonathan H. Watanabe Jonathan H. Watanabe (= 1×) peers Christopher Zacker

Countries citing papers authored by Jonathan H. Watanabe

Since Specialization

Citations

This map shows the geographic impact of Jonathan H. Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan H. Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan H. Watanabe more than expected).

Fields of papers citing papers by Jonathan H. Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan H. Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan H. Watanabe. The network helps show where Jonathan H. Watanabe may publish in the future.

Co-authorship network of co-authors of Jonathan H. Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan H. Watanabe. A scholar is included among the top collaborators of Jonathan H. Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan H. Watanabe. Jonathan H. Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watanabe, Jonathan H., et al.. (2025). Insulin Glargine Utilization and Spending Before and After the First Biosimilar Insulin Glargine: A Real-World Data Study. Journal of General Internal Medicine.

Watanabe, Jonathan H.. (2024). Enhancing drug evaluation in diverse populations and older adults: National Academies of Sciences, Engineering, and Medicine considerations. Journal of the American Geriatrics Society. 72(9). 2912–2920.

Watanabe, Jonathan H., et al.. (2024). Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States. SHILAP Revista de lepidopterología. 12(3). 94–94. 2 indexed citations

Watanabe, Jonathan H., et al.. (2024). Aspirin Use in Older People Highlights the Need for Improved Inclusion of Older People in Clinical Trials. The Senior Care Pharmacist. 39(6). 209–211.

Watanabe, Jonathan H., et al.. (2023). Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022. Journal of the American Pharmacists Association. 64(1). 133–138. 86 indexed citations breakdown →

Watanabe, Jonathan H.. (2023). Improving Care for Opioid Use Disorder in Nursing Facilities. The Senior Care Pharmacist. 38(8). 309–310. 1 indexed citations

Saunders, Ila M., et al.. (2023). Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States. PharmacoEconomics - Open. 7(3). 393–404. 10 indexed citations

Watanabe, Jonathan H., et al.. (2022). Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large Statewide Health System During the Pandemic in 2020. Journal of Pharmacy Technology. 38(2). 75–87. 1 indexed citations

Chan, Kelly, et al.. (2022). Effects of financial toxicity on prescription drug use and mental well-being in cancer patients. SHILAP Revista de lepidopterología. 6. 100136–100136. 7 indexed citations

10.

Davidson, Judy E., Mary Faith Marshall, & Jonathan H. Watanabe. (2019). Policy impact: When policy fails. Nursing Forum. 55(1). 37–44. 5 indexed citations

11.

Awdishu, Linda, Renu Singh, Ila M. Saunders, et al.. (2019). Advancing Pharmacist Collaborative Care within Academic Health Systems. SHILAP Revista de lepidopterología. 7(4). 142–142. 15 indexed citations

12.

Maldaun, Marcos Vinícius Calfat, et al.. (2018). Minimally Invasive Interhemispheric Approach for Giant Olfactory Groove Meningioma: Technical Note. World Neurosurgery. 120. 316–319. 3 indexed citations

13.

Watanabe, Jonathan H.. (2016). Medication Use, Falls, and Fall-Related Worry in Older Adults in the United States. The Consultant Pharmacist. 31(7). 385–393. 14 indexed citations

14.

Dilokthornsakul, Piyameth, R. Brett McQueen, Nathorn Chaiyakunapruk, et al.. (2016). Value of Information in Asia: Concepts, Current Use, and Future Directions. Value in Health Regional Issues. 9. 99–104. 1 indexed citations

15.

Watanabe, Jonathan H. & John P. Ney. (2014). Association of increased emergency rooms costs for patients without access to necessary medications. Research in Social and Administrative Pharmacy. 11(4). 499–506. 3 indexed citations

16.

Alfonso‐Cristancho, Rafael, et al.. (2013). Are Generic Drugs Defined and Classified Consistently Around the World?. Value in Health. 16(7). A672–A672. 1 indexed citations

17.

Ney, John P., Emily Beth Devine, Jonathan H. Watanabe, & Sean D. Sullivan. (2013). Comparative Efficacy of Oral Pharmaceuticals for the Treatment of Chronic Peripheral Neuropathic Pain: Meta-Analysis and Indirect Treatment Comparisons. Pain Medicine. 14(5). 706–719. 29 indexed citations

18.

Ney, John P., David N. van der Goes, & Jonathan H. Watanabe. (2012). Cost-effectiveness of intraoperative neurophysiological monitoring for spinal surgeries: Beginning steps. Clinical Neurophysiology. 123(9). 1705–1707. 34 indexed citations

19.

Sand, Peter K., Eric S. Rovner, Jonathan H. Watanabe, & Michael G. Oefelein. (2011). Once-Daily Trospium Chloride 60 mg Extended Release in Subjects with Overactive Bladder Syndrome Who Use Multiple Concomitant Medications. Drugs & Aging. 28(2). 151–160. 14 indexed citations

20.

Watanabe, Jonathan H., Jonathan D. Campbell, Arliene Ravelo, et al.. (2010). Cost Analysis of Interventions for Antimuscarinic Refractory Patients With Overactive Bladder. Urology. 76(4). 835–840. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact